S2 Episode 4: Tech Geek: The Latest in Type 2 Diabetes Wearables and Devices

S2 Episode 4: Tech Geek: The Latest in Type 2 Diabetes Wearables and Devices

Opportunities abound to upgrade your technology in type 2 diabetes patient care. Join Dr Carol Wysham and nurse practitioner Davida F. Kruger in a discussion on the latest wearables and devices.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982417). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

SGLT2 Inhibitors and GLP-1 Receptor Agonists: Established and Emerging Indications https://pubmed.ncbi.nlm.nih.gov/34216571/

How May GIP Enhance the Therapeutic Efficacy of GLP-1? https://pubmed.ncbi.nlm.nih.gov/32396843/

Continuous Glucose Monitoring in Primary Care – Are We There? https://pubmed.ncbi.nlm.nih.gov/34845158/

Finger-Stick Glucose Monitoring: Issues of Accuracy and Specificity https://pubmed.ncbi.nlm.nih.gov/20351231/

FreeStyle Libre 3: "Almost Like Wearing Nothing" https://www.medscape.com/viewarticle/979580

FDA Okays Dexcom G7 Continuous Glucose Monitoring System https://www.medscape.com/viewarticle/985274

InPen https://www.medtronicdiabetes.com/products/inpen-smart-insulin-pen-system

Patch Pumps for Insulin https://pubmed.ncbi.nlm.nih.gov/30070604/

Avsnitt(18)

S3 Episode 6: Continuous Glucose Monitoring in Clinical Type 2 Diabetes Practice: Benefits, Accessibility, and Patient Resistance

S3 Episode 6: Continuous Glucose Monitoring in Clinical Type 2 Diabetes Practice: Benefits, Accessibility, and Patient Resistance

Drs Carol H. Wysham and Grazia Aleppo discuss how and when to use CGM in clinical type 2 diabetes practice, navigating patient resistance, and benefits in gestational diabetes. Relevant disclosures ca...

25 Juni 202521min

S3 Episode 5: Choosing Which Agents to Use in the Management of CKD in Type 2 Diabetes Patients: SGLT2 Inhibitors vs GLP-1s

S3 Episode 5: Choosing Which Agents to Use in the Management of CKD in Type 2 Diabetes Patients: SGLT2 Inhibitors vs GLP-1s

Drs Carol H. Wysham and Liana K. Billings discuss how to incorporate SGLT2 inhibitors and GLP-1 receptor agonists into the management of patients with type 2 diabetes and chronic kidney disease. Relev...

22 Maj 202522min

S3 Episode 4: Heart Failure, Incretin Therapies, and Type 2 Diabetes

S3 Episode 4: Heart Failure, Incretin Therapies, and Type 2 Diabetes

Drs Carol H. Wysham and Christopher M. Kramer discuss heart failure and type 2 diabetes, and the role of incretin therapies in the management of HFpEF. Relevant disclosures can be found with the episo...

24 Apr 202521min

S3 Episode 3: 2025 ADA Updates: Comorbidities, Dental Care, Weight Loss, Sexual Dysfunction, and CGM Use for Type 2 Diabetes

S3 Episode 3: 2025 ADA Updates: Comorbidities, Dental Care, Weight Loss, Sexual Dysfunction, and CGM Use for Type 2 Diabetes

Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use. Relevant disclosures can...

25 Mars 202524min

S3 Episode 2: Treating Type 2 Diabetes in an Aging Population: Geriatric Syndromes, Comorbidities, and Treatment De-escalation

S3 Episode 2: Treating Type 2 Diabetes in an Aging Population: Geriatric Syndromes, Comorbidities, and Treatment De-escalation

Drs Carol H. Wysham and Medha Munshi discuss type 2 diabetes in older adults, understanding geriatric syndromes and how they impact care, and when to de-escalate treatment. Relevant disclosures can be...

25 Feb 202522min

S3 Episode 1: Screening and Management of Metabolic Dysfunction-Associated Fatty Liver Disease in Endocrine Practice

S3 Episode 1: Screening and Management of Metabolic Dysfunction-Associated Fatty Liver Disease in Endocrine Practice

Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction–associated steatotic liver disease in endocrine practice. Relevant disclosures can be f...

25 Feb 202521min

S2 Episode 6: What's Next? Emerging Trends in Type 2 Diabetes Management

S2 Episode 6: What's Next? Emerging Trends in Type 2 Diabetes Management

Join Drs Carol Wysham and Silvio Inzucchi as they discuss how type 2 diabetes management has evolved over the years, and the most promising developments on the horizon. Relevant disclosures can be fou...

1 Juni 202324min

S2 Episode 5: Weight Management as a Goal in Type 2 Diabetes Care

S2 Episode 5: Weight Management as a Goal in Type 2 Diabetes Care

Join Drs Carol Wysham and Carel le Roux for practical, actionable strategies when targeting weight management as a key goal in type 2 diabetes prevention and treatment. Relevant disclosures can be fou...

3 Maj 202320min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
rss-vetenskapsradion
det-morka-psyket
rss-spraket
rss-ufo-bortom-rimligt-tvivel-2
medicinvetarna
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
hacka-livet
sexet
rss-tidslinjen-podcast
dumforklarat
halsorevolutionen
har-vi-akt-till-mars-an
4health-med-anna-sparre
doden-hjarnan-kemisten